semaglutide / tirzepatide Semaglutide, recommended as first-line treatment of obesity and most of its complications in new guidance Switching Between Semaglutide and Tirzepatide:

Starting doses remain conservative regardless of weight loss goals

Bovendien verloor 89% tot 91% van de patinten 5% of meer van hun gewicht, wat als klinisch significant wordt beschouwd voor het verbeteren van de metabolische gezondheid

Even though obesity is a recognized medical condition, many insurance plans, especially Medicare, do not cover weight-loss medications

Another indirect comparison study showed that Zepbound was more effective in reducing weight, with a higher percentage of participants achieving at least 5% weight loss

Key takeaways You should take Mounjaro once weekly on the same day each week at a time that fits your schedule to maximize efficacy and minimize possible side effects

The therapeutic success of GLP-1 receptor agonists, which modulate both sweet taste perception and the hedonic valuation of food, underscores the potential of targeting this integrative system